A phase I study of HER1, HER2 dual kinase inhibitor...

  • Main
  • 2019 / 9
  • A phase I study of HER1, HER2 dual kinase inhibitor...
Cancer Chemotherapy and Pharmacology 2019 / 9

A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies

Lynce, Filipa, Wang, Hongkun, Petricoin, Emanuel F., Pohlmann, Paula R., Smaglo, Brandon, Hwang, Jimmy, He, Aiwu R., Subramaniam, Deepa S., Deeken, John, Marshall, John, Pishvaian, Michael J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-019-03947-7
Date:
September, 2019
File:
PDF, 608 KB
english, 2019
Conversion to is in progress
Conversion to is failed